Givaudan | GIVN - Des Atouts





Des Atouts Changement Date
Air Liquide EUR 56.28B 4.36B 2026-06
Akzo Nobel EUR 16.13B 647M 2026-06
Anheuser-Busch USD 218.39B 423M 2026-06
Arkema EUR 14.17B 48.4M 2026-06
Associated British Foods GBP 19.29B 608M 2025-12
BASF EUR 83.87B 2.1B 2026-06
Bayer EUR 107.29B 659M 2026-06
Beiersdorf EUR 12.76B 166M 2025-12
British American Tobacco GBP 108.39B 902M 2026-06
Covestro EUR 13.47B 245M 2025-12
Croda International GBP 3.51B 70.1M 2024-12
Danone EUR 48.62B 3.55B 2026-06
Diageo GBP 46.85B 3.43B 2026-06
Fresenius EUR 41.84B 526M 2026-06
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
Givaudan CHF 11.86B 587M 2025-12
Heineken EUR 58.04B 4.29B 2026-06
Henkel EUR 36.5B 3.96B 2026-06
International Flavors Fragrances USD 25.15B 10M 2026-06
Johnson Matthey GBP 5.97B 142M 2026-06
Kerry EUR 11.15B 479.8M 2026-06
Lonza CHF 18.97B 164M 2025-12
L'Oréal EUR 66.35B 4.53B 2026-06
Merck EUR 52.69B 383M 2026-06
Nestle CHF 128.38B 1.23B 2026-06
Pernod Ricard EUR 37.3B 379M 2026-06
Reckitt Benckiser GBP 25.3B 1.11B 2024-12
SGS CHF 6.75B 148M 2024-12
Sika AG CHF 15.15B 245M 2025-12
Solvay EUR 6.08B 122M 2026-06
Tate & Lyle GBP 3.67B 67M 2026-06
Umicore EUR 10.06B 603.5M 2026-06
Victrex GBP 505.3M 61.6M 2026-06